Evidence map›Paper›PMID 40898208›Full record

ArticleMalaria journal2025

MALDI-TOF MS for identification of Afro-tropical secondary malaria vectors.

Mercy Tuwei, Jonathan Karisa, Caroline Wanjiku, Caroline Kiuru, Zedekiah Ondieki, Tobias Odongo, Festus Mure, Bruno Otieno, Peter Meli, Miguel Okoko and 18 more

Abstract read
In one paragraph

Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Mercy TuweiKenya Medical Research Institute, Wellcome Trust Research Program, P.O. Box 230-80108, Kilifi, Kenya. mercytuweij@gmail.com.
Jonathan KarisaKenya Medical Research Institute, Wellcome Trust Research Program, P.O. Box 230-80108, Kilifi, Kenya.
Caroline WanjikuKenya Medical Research Institute, Wellcome Trust Research Program, P.O. Box 230-80108, Kilifi, Kenya.
Caroline KiuruCentro de Investigação em Saúde de, Manhiça, Moçambique.
Zedekiah OndiekiKenya Medical Research Institute, Wellcome Trust Research Program, P.O. Box 230-80108, Kilifi, Kenya.
Tobias OdongoKEMRI Centre for Geographic Medicine Research - Coast, Kilifi, Kenya.
Festus MureKEMRI Centre for Geographic Medicine Research - Coast, Kilifi, Kenya.
Bruno OtienoKEMRI Centre for Geographic Medicine Research - Coast, Kilifi, Kenya.
Peter MeliKEMRI Centre for Geographic Medicine Research - Coast, Kilifi, Kenya.
Miguel OkokoKEMRI Centre for Geographic Medicine Research - Coast, Kilifi, Kenya.
Brian BartilolKEMRI Centre for Geographic Medicine Research - Coast, Kilifi, Kenya.
Rehema GonaKEMRI Centre for Geographic Medicine Research - Coast, Kilifi, Kenya.
Luis ConstantinoCentro de Investigação em Saúde de, Manhiça, Moçambique.
Gildo ColeCentro de Investigação em Saúde de, Manhiça, Moçambique.
Trisa AnastácioCentro de Investigação em Saúde de, Manhiça, Moçambique.
Romário ArmaziaCentro de Investigação em Saúde de, Manhiça, Moçambique.
Claudia AlvesCentro de Investigação em Saúde de, Manhiça, Moçambique.
Picardo RuiCentro de Investigação em Saúde de, Manhiça, Moçambique.
Edith RamaitaDivision of National Malaria Programme, Ministry of Health, Nairobi, Kenya.
Martin RonoKEMRI Centre for Geographic Medicine Research - Coast, Kilifi, Kenya.
Baltazar CandrinhoNational Malaria Control Program, Maputo, Mozambique.
Joseph MwangangiKEMRI Centre for Geographic Medicine Research - Coast, Kilifi, Kenya.
Charles MbogoKEMRI Centre for Geographic Medicine Research - Coast, Kilifi, Kenya.
Derek CharlwoodInstituto de Higiene e Medicine Tropical, Lisbon, Portugal.
Francisco SauteCentro de Investigação em Saúde de, Manhiça, Moçambique.
Regina RabinovichBarcelona Institute for Global Health, Hospital Clínic - Universitat de Barcelona, Carrer Roselló 132, 08036, Barcelona, Spain.
Carlos ChaccourBarcelona Institute for Global Health, Hospital Clínic - Universitat de Barcelona, Carrer Roselló 132, 08036, Barcelona, Spain.
Marta Ferreira MaiaKenya Medical Research Institute, Wellcome Trust Research Program, P.O. Box 230-80108, Kilifi, Kenya. mmaia@kemri-wellcome.org.

Funding

Bill and Melinda Gates Foundation INV-057212
6 · The paper itself

Abstract

backgroundCharacterizing malaria epidemiology at the local level requires understanding the diverse malaria vector species driving transmission, including both primary and secondary vectors. Effective mosquito surveillance and accurate species identification are critical; however, due to the associated cost and complexity, most surveillance strategies mainly focus on the primary malaria vectors. There is a need for cost-effective methods that can reliably identify both primary and secondary vectors as their role in transmission becomes increasingly important while reaching towards elimination. This study aimed to evaluate the use of MALDI-TOF MS as a sustainable tool for identifying secondary malaria vector.

methodsAdult mosquitoes were collected in Kenya and Mozambique and morphologically identified. Secondary malaria vectors were considered as any Anopheline that did not pertain to Anopheles gambiae sensu lato (s.l.). or Anopheles funestus sensu lato (s.l.). At KEMRI Wellcome Trust Research Programme, MALDI TOF MS spectra were obtained from individual cephalothoraxes. Library creation and querying were guided by confirmatory species identification using Sanger sequencing of a subset of mosquitoes, targeting the Internal Transcribed Spacer 2 (ITS2) region of nuclear ribosomal DNA and the mitochondrial Cytochrome c Oxidase Subunit I (COI) gene. The libraries were then applied for the identification of other secondary malaria vectors.

resultsSpecies identification of secondary malaria vectors using MALDI-TOF MS showed high concordance with Sanger sequencing with an overall accuracy of 91% and a kappa value of 0.87. The technique demonstrated a sensitivity and specificity of 100% for most species, except for distinguishing between Anopheles cf. coustani 2 NFL-2015 and Anopheles ziemanni. In Kenya, the Anopheles species identified were Anopheles cf. coustani 2 NFL-2015 (19), Anopheles pretoriensis (6), Anopheles rufipes (8), Anopheles ziemanni (8), Anopheles coustani (2), and Anopheles pharoensis (1). In Mozambique, the identified species comprised: An. cf. coustani 2 NFL-2015 (10), An. pretoriensis (2), An. ziemanni (7), An. coustani (28), and An. pharoensis (4).

conclusionThe results provide evidence that MALDI-TOF can identify secondary malaria vectors from Eastern and Southeastern African regions. This technique was as efficient as DNA sequencing in identifying mosquito species. Indeed, except for An. cf coustani 2NFL-2015 and An. ziemanni, an exact species identification was obtained for all individual mosquitoes. These findings highlight the potential of MALDI-TOF MS for monitoring malaria vectors.

Indexed as

AnophelesMosquito VectorsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAnimalsKenyaMalariaMozambiqueAnopheles cf. coustani 2 NFL-2015Anopheles coustaniAnopheles pharoensisAnopheles rufipesBio-typingKenyaMALDI-TOF MSMozambiqueSecondary malaria vectorsSpecies identification

Identifiers

PMID40898208
PMCPMC12403918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.